Abstract
Cobra venom factor (CVF), a nontoxic, complement-activating glycoprotein in cobra venom, is a functional analog of mammalian complement component C3b. The carbohydrate moiety of CVF consists exclusively of N-linked oligosaccharides with terminal α1-3-linked galactosyl residues, which are antigenic in human. CVF has potential for several medical applications, including targeted cell killing and complement depletion. Here, we report a detailed structural analysis of the oligosaccharides of CVF. The structures of the oligosaccharides were determined by lectin affinity chromatography, antibody affinity blotting, compositional and methylation analyses, and high-resolution 1H-NMR spectroscopy. Approximately 80% of the oligosaccharides are diantennary complex-type, Ο12% are tri- and tetra-antennary complex-type, and Ο8% are oligomannose type structures. The majority of the complex-type oligosaccharides terminate in Galα1-3Galβ1-4(Fucα1-3)GlcNAcβ1, a unique carbohydrate structural feature abundantly present in the glycoproteins of cobra venom.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 195-208 |
| Number of pages | 14 |
| Journal | Glycobiology |
| Volume | 11 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2001 |
All Science Journal Classification (ASJC) codes
- General Medicine
Fingerprint
Dive into the research topics of 'N-linked oligosaccharides of cobra venom factor novel α(1-3)galactosylated LeX structures'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver